论文部分内容阅读
目的比较多重耐药菌医院感染和社区感染患者的住院时间和费用的差异。方法选定2015年1月1月-2016年12月30日发生的多重耐药菌医院感染患者173例为病例组,按年龄、入院诊断、同期住院等因素进行1∶3条件进行配对,抽取510例社区多重耐药菌感染患者作为对照组,比较2组患者住院天数、抗菌药物使用及联用天数和住院费用的差异。结果病例组患者住院天数、抗菌药物使用及联用天数均长于对照组,差异均有统计学意义(P<0.01或P<0.05)。病例组住院总费用为38 874元高于对照组的19 917元,差异有统计学意义(Z=-5.406,P<0.01)。结论与多重耐药菌社区感染相比,多重耐药菌医院感染延长了患者住院时间、抗菌药物使用和联用时间,增加了住院费用,医务人员应积极落实多重耐药菌医院感染防控措施,降低多重耐药菌医院感染的发生率。
Objective To compare the differences in hospitalization time and cost between patients with nosocomial infections and community-acquired infections. Methods A total of 173 multi-drug resistant hospital-acquired nosocomial infections from January 2015 to December 30, 2016 were selected as the case group and paired according to the age, admission diagnosis, hospitalization in the same period, 510 patients with multi-drug-resistant bacterial community infection as a control group, compared the length of stay in hospital patients, antimicrobial use and combined days and hospitalization costs differences. Results The days of hospitalization, the use of antimicrobial agents and the days of combination were longer in the case group than in the control group, with statistical significance (P <0.01 or P <0.05). The total hospitalization cost of the case group was 38 874 yuan higher than the control group 19 917 yuan, the difference was statistically significant (Z = -5.406, P <0.01). Conclusion Compared with the multi-drug resistant community infection, multi-drug resistant hospital nosocomial infection prolongs hospitalization time, antibacterial use and combination time, increases the cost of hospitalization, and medical staff should actively implement multi-drug resistant hospital infection prevention and control measures , Reduce the incidence of multi-drug resistant hospital infection.